3 Stocks I Plan to Hold for the Next 20 Years

The article highlights three long-term compounders: Nintendo, Oscar Health, and Adyen. Nintendo’s Switch 2 is off to a strong start with 20 million units sold last fiscal year and game sales like Mario Kart World at 15 million copies; Oscar Health reached 3.2 million paying customers and is guiding to $19B in revenue and $250M-$450M in operating earnings; Adyen’s Q1 2026 processed volume rose 21% and revenue increased 20% in constant currency. The piece is broadly bullish on all three stocks, emphasizing durable demand, market-share gains, and large upside from current depressed valuations.

Analysis

The common thread across the three names is not just “durable businesses,” but operating leverage embedded in platform economics: each one is at an inflection where incremental volume should outgrow incremental cost. That creates a second-order effect for competitors — once the leader locks in distribution or checkout performance, rivals have to spend disproportionately more on acquisition, subsidies, or infrastructure just to hold share. In that setup, the market often misprices the durability of margins because it extrapolates near-term cost pressure rather than the longer-lived compounding of unit economics.

OSCR is the clearest near-term catalyst story because the core debate is no longer viability, but how fast scale converts into underwriting credibility and lower churn. If execution holds, the next leg is not just revenue growth but better loss ratio optics, which can re-rate the stock faster than absolute earnings growth would suggest. The main risk is that growth in membership is easy to see, while deterioration in risk pool quality usually shows up with a lag of 2-4 quarters; that makes this a classic “good story until reserve noise appears” setup.

For SPOT and UBER, the article’s real signal is that investors are still paying too little for the embedded optionality in advertising and marketplace monetization. The contrarian point is that both businesses can look “expensive” on current earnings while still being cheap on mid-cycle cash flow if take rates and attach rates keep compounding for several years. The flip side is that any slowdown in consumer spend or ad budgets will hit sentiment quickly, so these are better expressed as staggered entries or call structures rather than full-size cash longs.

Key Decisions for Investors

• Long OSCR on pullbacks over the next 1-3 weeks; target a 6-12 month hold into the next reporting cycle where operating leverage and medical-cost stability can re-rate the stock. Risk/reward is attractive if the market continues to capitalize membership growth more than near-term expense volatility.
• Buy SPOT on a 3-6 month horizon as a quality compounder, but size modestly and prefer call spreads over outright equity to limit downside if ad-market sentiment softens. The asymmetry is in multiple expansion if margin durability becomes more visible.
• Use UBER as a relative-value long versus lower-quality consumer internet names over 6-12 months; the cleaner path is a pair trade long UBER / short a weaker platform with less pricing power. This isolates monetization durability from broader market beta.
• If entering all three, stage positions: 40% now, 30% on post-earnings volatility, 30% on any 10%+ drawdown. This reduces timing risk in names where the long-term thesis is strong but short-term headline risk can be noisy.
• Avoid chasing after sharp green days; these are better buys when the market is focused on quarterly noise rather than terminal economics. The best entry is when valuation compresses faster than the fundamental runway deteriorates.